Phreesia, Inc.
General ticker "PHR" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.1B (TTM average)
Phreesia, Inc. does not follow the US Stock Market performance with the rate: -28.8%.
Estimated limits based on current volatility of 1.8%: low 10.56$, high 10.94$
Factors to consider:
- Total employees count: 1789 (-14.1%) as of 2026
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Customer concentration, Market competition, Strategic risks and growth management, Capital access, Regulatory and compliance
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [11.32$, 24.04$]
- 2027-01-31 to 2028-01-31 estimated range: [10.44$, 22.18$]
Financial Metrics affecting the PHR estimates:
- Positive: with PPE of 95.2 at the end of fiscal year the price was low
- Positive: 6.62 < Operating cash flow per share per price, % of 8.66
- Positive: -5.34 < Operating profit margin, % of -1.36
- Negative: Investing cash flow per share per price, % of -17.79 <= -14.27
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: 0.74 < Interest expense per share per price, % of 0.76
- Positive: -3.72 < Return on assets ratio (scaled to [-100,100]) of 0.35
- Negative: 42.57 < Shareholder equity ratio, % of 50.80 <= 64.23
- Negative: negative Industry operating cash flow (median)
Short-term PHR quotes
Long-term PHR plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $356.30MM | $419.81MM | $480.59MM |
| Operating Expenses | $492.78MM | $477.91MM | $487.20MM |
| Operating Income | $-136.48MM | $-58.10MM | $-6.61MM |
| Non-Operating Income | $1.14MM | $2.29MM | $-2.33MM |
| Interest Expense | $1.85MM | $2.35MM | $6.95MM |
| R&D Expense | $112.35MM | $117.36MM | $121.48MM |
| Income(Loss) | $-135.34MM | $-55.81MM | $-8.94MM |
| Taxes | $1.54MM | $2.72MM | $-11.25MM |
| Net Income(Loss)* | $-136.88MM | $-58.53MM | $2.31MM |
| Stockholders Equity | $251.45MM | $264.81MM | $337.21MM |
| Inventory | $0.77MM | $0.00MM | $0.00MM |
| Assets | $370.33MM | $388.42MM | $663.79MM |
| Operating Cash Flow | $-32.38MM | $32.38MM | $78.81MM |
| Capital expenditure | $25.10MM | $24.09MM | $11.10MM |
| Investing Cash Flow | $-39.67MM | $-24.09MM | $-161.88MM |
| Financing Cash Flow | $-17.11MM | $-11.49MM | $72.85MM |
| Earnings Per Share** | $-2.51 | $-1.02 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.